| Financial Year |
March 31 2023 |
| Monetary Funds |
3,047,445,237.94 |
| Held-for-trading Financial Assets |
761,459,711.56 |
| Notes Receivable |
13,285,568.19 |
| Accounts Receivable |
61,692,068.23 |
| Advances to Suppliers |
257,255,774.19 |
| Other Receivables |
10,075,263.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,072,645,007.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,327,624.77 |
| Total Current Assets |
5,270,227,236.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
758,269,043.93 |
| Investment Properties |
396,170,666.74 |
| Fixed Assetes |
45,558,044.41 |
| Under-construction Projects |
210,679,276.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
122,007,360.33 |
| R&D expenses |
-- |
| Goodwill |
214,120,399.74 |
| Long-Term Deferred and Prepaid Expenses |
3,992,003.03 |
| Deferred Income Tax Assets |
252,377,652.43 |
| Other Non-Current Assets |
259,358,691.00 |
| Sub-Total of Non-Current Assets |
4,594,838,760.09 |
| Total Assets |
9,865,065,996.40 |
| Short-Term Loans |
334,776,889.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
141,661,316.98 |
| Accounts Received In Advance |
2,796,707.30 |
| Employee Compensation Payable |
11,485,056.65 |
| Taxes Payable |
107,896,630.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,316,774.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,374,258.92 |
| Other Current Liabilities |
1,755,000.00 |
| Sub-Total of Current Liabilities |
848,554,731.47 |
| Long-term Loans |
30,200,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
120,172,911.51 |
| Deferred Income Tax Liabilities |
279,359,413.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
572,336,635.29 |
| Total Liabilities |
1,420,891,366.76 |
| Paid-In Capital(Or Share Stock) |
930,629,920.00 |
| Capital Surplus |
198,488,485.67 |
| Surplus Reserve |
1,079,702,167.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,530,438,099.21 |
| Minority Stockholder's Interest |
61,263,414.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,382,911,215.10 |
| Owner's Equity（Stockholder's Equity） |
8,444,174,629.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,865,065,996.40 |
